Ivenix, Inc., a medical technology company with a vision to eliminate infusion-related patient harm, was founded in 2012 to develop innovative solutions that transform infusion delivery. Designed from the ground up to streamline medication delivery and bring legacy technology into the digital age, the Ivenix Infusion System includes a large-volume infusion pump supported by a robust infusion management system designed to set new standards in usability, medication precision and interoperability.
Founders’ story
Today’s IV smart pumps rely on technology developed more than a decade ago and continue to put patients at risk. At Ivenix, we believe it’s more important than ever to empower clinicians with the most effective infusion equipment, training and processes to ensure they do no harm. No hospital wants to wonder: “Are we doing enough? Are we making every effort to prevent infusion mistakes?” We are all patients. And Ivenix is dedicated to the belief that infusion technology should put patients first with enhanced outcomes and a better patient experience, while dramatically improving clinical workflow and efficiency. It’s what inspires us, motivates us, and brings us together for the shared purpose of delivering groundbreaking infusion innovation to healthcare.
Marketing/promotion strategy
Ivenix is generating awareness through a number of channels, and has partnered with industry associations, such as HIMSS, IHE and AAMI, which has an Infusion Safety Therapy Coalition, to address current market issues in infusion safety, interoperability and innovation. Ivenix is also testing its infusion pump system with a number of integration partners, including leading EMR, alarms management and clinical communication vendors to provide interoperability solutions.
Market opportunity
Ivenix is addressing the $9 billion global infusion pump market, with first targeted efforts on the U.S. large volume pump market, a $2..6 billion market segment that represents the majority of infusion pumps used in the U.S. hospital and ancillary clinic market.
Who are your competitors?
Braun, BD, ICU Medical, Baxter
How your company differentiates itself from the competition and what differentiates Ivenix?
Ivenix has developed an infusion platform to address an industry fraught with medication errors. Infusion-related errors account for more than 50 percent of the 1.5 million adverse drug events reported annually to the U.S. Food and Drug Administration (FDA). Between 2015 and 2017, more than 23,000 pump malfunctions, including subsequent injuries, were reported to the FDA. With today’s pumps, infusion errors are attributed to error-prone programming tasks, usability issues and clinical use, inaccurate flow, hardware failures and outdated designs with limited information. Currently, less than 1 percent of IV pumps are fully integrated with electronic medical records. Ivenix is rethinking infusion delivery to set new standards in safety, simplicity, and interoperability, Ivenix designed its infusion system on three fundamental dimensions:
Patient-centered design: Intuitive design enables faster bedside setup and lowers risk of programming errors, benefiting patients because clinicians spend less time troubleshooting pumps or resolving nuisance alarms.
Integrated data-driven insights: Advanced IT platform integrates with the EMR and other hospital information systems, securely manages data and connects clinicians with patient-specific knowledge to be better informed – and therefore make better decisions – at the bedside.
Adaptive fluid delivery: Advanced pump technology reduces clinical variability of medication delivery to help improve patient outcomes.
CarePort Health provides post-acute care management solutions for hospitals, payers, ACOs and post-acute providers to better manage patient care across the continuum.
Elevator pitch
CarePort Health bridges the data gap between acute and post-acute care to help improve patient outcomes.
Founders’ story
Since CEO and co-founder Dr. Lissy Hu immigrated from China to the U.S. at seven years old, Hu has been immersed in the healthcare landscape. Her mother worked as a home health aide helping vulnerable populations so, at an early age, Hu learned the compassion and hard work that went into helping patients. It was through her family’s influence that Hu decided to dedicate her career to helping underserved and vulnerable patient populations. After completing her pre-med at Columbia University, Hu did a healthcare fellowship where she worked with 3,000 high-cost Medicare patients in the Bronx. It was here that she was exposed to the gaps between acute and post-acute care – ultimately, there was no way to know how her patients were doing once they left the hospital setting. This black hole her patients were going into once discharged left Hu perplexed, but also motivated to do something about it. After her fellowship, Hu pursued a joint MD/MBA from Harvard. During that time, she developed the idea that is now CarePort, launching the company after winning a business plan competition in 2012. In 2016, CarePort Health was acquired by Allscripts, one of the largest EHR solutions providers. The company’s Boston-based team recently moved into a new, larger office space to accommodate its expanding team.
Marketing/promotion strategy
CarePort Health partners with hospitals, payers, accountable care organizations (ACOs) and post-acute providers to give access to its suite of solutions including CarePort Guide, CarePort Connect and CarePort Insight. The shift to value-based care has motivated healthcare organizations and their providers to have a heightened lens on patient health beyond the hospital, and CarePort is one solution that provides that level of visibility.
Market opportunity
CarePort’s customers are primarily hospitals, payers, ACOs and post-acute providers like skilled nursing facilities. One-in-five patients are admitted to post-acute care after being discharged from the hospital – nearly 8 million patients annually. With an aging population, this number is set to increase. Today, most patients that need post-acute care are handed a piece of paper by the nurse or physician that includes a list of names and addresses – no other context. Not only is this a confusing time for the patient, but also their families. Having to decide where they receive care next based off a list of names does not provide proper guidance into the type of care they will receive. By leveraging CarePort Health’s suite of solutions, providers and their patients can look deeper into the facilities being suggested and make a more informed clinical decision.
The CarePort platform consists of three tools to improve post-acute outcomes:
CarePort Guide: Simplifies post-acute provider selection to make it as informed and intuitive as booking a hotel.
CarePort Connect: Empowers providers across the continuum – hospitals, payers, ACOs, and post-acute providers – to coordinate care through real-time information sharing. Intuitive and web-based, CarePort Connect breaks down silos of patient information to connect previously disparate providers with shared patients through real-time, actionable data sharing.
CarePort Insight: Provides organizations with real-time analytical reports that are easily generated with multiple drill-down options and filters for provider, patient type and/or condition.
Care Management – A complete Acute Case Management, Discharge Planning and Utilization Review workflow tool with a built-in network of more than 20,000 providers.
Referral Management – An intake, referral management and discharge planning tool for post-acute care providers.
Who are your competitors?
CarePort Health has designed tools unique to the market and, therefore, does not have direct competitors. There are a few companies in the market that have similar tools. However, CarePort Health is the only company that utilizes rich data sets to provide a much more comprehensive look into post-acute care settings for each patient.
How does your company differentiate itself from the competition and what differentiates CarePort Health?
CarePort Health is the only company that has developed three unified tools to help providers and their patients make more informed decisions for post-acute care management. Patients are no longer making decisions based off a flat list of names and addresses. CarePort’s technology allows them to look at the full spectrum of the care being offered by each facility and how it can meet their healthcare needs.
Greenlight Guru is the only quality management software designed specifically for the medical device industry.
Elevator pitch
Get to market faster with less risk and achieve true quality.
Founders’ story
The seeds for Greenlight Guru were planted back in 2006 by Jon Speer, a medical device engineer turned consultant as a result of a simple observation: paper-based quality management systems are painful, risky & wildly inefficient. Commercial quality management software solutions have been available for over 20 years now, yet only about 30 percent of medical device companies that should be using them were. This observation and question led Jon Speer to team up with David DeRam to create the vision for a beautifully simple quality management software.
Marketing/promotion strategy
Greenlight Guru partners with trade publications and frequently hosts webinars to help medical device startup founders plot a clear course through the complicated regulatory environment.
Market opportunity
Quality management solutions existed, or could be engineered to work, for nearly every industry. Because of to the complicated nature of medical device regulatory compliance in the United States, Canada and the European Union one of two things was happening: 1. Systems not meant for medical devices were being rigged to work or, 2. An unorganized, not easily searched paper-based QMS was developed.
Greenlight Guru was developed to help medical device manufacturers manage documents, manage risk, perform quality management and log and address customer complaints in an easy to use cloud-based platform.
Who are your competitors?
Greenlight Guru is the only QMS system built specifically for the medical device industry. Non-industry specific QMS systems exist; however, they often have to be heavily modified to handle even the most mundane tasks in the medical device industry. As a result, Greenlight Guru helps device manufacturers spend more time on their product, and less time on paperwork.
How your company differentiates itself from the competition and what differentiates Greenlight Guru?
Greenlight Guru consists of three systems meant to help device manufacturers “GO” to market, “GROW” in the market, and “GURU” to provide regulatory expertise to device makers. This three pronged approach helps manufacturers through the full life-cycle of the product.
Business model
Greenlight Guru has a B2B business model with systems mean to help device makers “GO” to market, “GROW” in the market and “GURUs” to help stay in the market.
Current needs
Greenlight Guru is always looking for talented individuals with a willingness to work hard and improve the quality of life for our users.
YourDoctors.Online provides patients direct access to the North American doctors. The company’s general physicians are available online to answer any general inquiry and experienced specialists for second opinions.
Elevator pitch:
We are like WebMD but with a personal touch. Connect with a personal doctor 24/7 to get personalized answers to your medical questions with an “opinion that matters.”
Founder story:
CEO Nauman Jaffar’s mother, aunt and boss were diagnosed with chronic diseases. Some survived due to on-time proper diagnosis while others were not that lucky. This motivated him to leave my corporate life and create a solution that connects global patients to world-class doctors. Our mission is to develop a social enterprise focused on preventing misdiagnosis and ensuring that excellent healthcare is a “click” away. We aspire to save one life at a time with medical “opinion that matters”.
Marketing/promotion strategy:
YourDoctors.Online is directly reaching out to consumers all across the world to connect patients with internet access to North American doctors get access to the best medical advice. We communicate through a variety of digital channels to not only stay top of mind but to gain awareness that getting the right medical advice is a few clicks away.
Market opportunity:
Our target audience and marketing focus is towards women from the ages between 20-35 and who for an online doctor service for their family.
Who are your competitors?
Because of the service YourDoctors.Online provides, we have no direct competitors. Companies, such as Best Doctors, 2nd.MD, do offer a similar service; however, instead of directly targeting companies and their employees, we directly going out to consumers. As a result, our patients are from 125 different countries.
How your company differentiates itself from the competition and what differentiates YourDoctors.Online?
With direct access to our customer, our competitive advantages is our brand value and our valued pricing for a medical second opinion. Since our market is international patient with various different affordability ranges, we provide our patients with access to doctors at affordable rates.
Business Model:
We have three different tiers of services such as 1) specialist who provide a medical second opinion for a premium price; 2) for our monthly members who get access to our auxiliary medical practitioners (i.e. psychologist, nutritionist, etc.); and 3) free access to our general physicians.
Intiva Health is the first truly integrated career platform for healthcare professionals. It redefines the medical credentialing process by making it faster, more efficient and more secure.
Elevator pitch
Intiva Health provides healthcare professionals with a single place to manage their credentials,continuing education, new job opportunities, secure messaging needs and more. It is built on the Hashgraph digital ledger platform, which means it is faster, more secure, and more error proof than blockchain.
Founders’ story
Intiva Health was founded in 2006 as a staffing agency for surgical services and emergency rooms. Today the Austin, Texas company it has reinvented itself as a digital health startup featuring a next generation blockchain technology that cuts the time it takes for the medical credentialing process from months to seconds, improves HIPAA compliance,and makes document tampering or theft almost impossible.
Marketing/promotion strategy
Intiva Health focuses its marketing and PR efforts on licensed medical professionals (LMPs), practice managers, and the facilities where they work including medical groups, hospitals and professional associations.The company launched a new brand awareness campaign in March 2018 that included the introduction of the Intiva Token, a new cryptocurrency that LMPs can use to purchase continuing education classes, cyber insurance and other services.
Intiva is also partnering with the National Osteoporosis Foundation to test the advantages of using the IntivaToken for charitable donations.
Market opportunity
The Intiva Health Platform automates the burdensome tasks of credential and licensure management, continuing education, and discovering job opportunities for healthcare professionals. Intiva Health’s new ReadyDoc™credential verification solution, built on top of the Hashgraph distributed ledger technology, disrupts the existing broken, slow, and error-prone healthcare credentialing system, which today can take weeks or months to verify credentials, and is subject to tampering.
Intiva believes that ReadyDoc can replace the current processes of credentialing and primary source verification by storing documents and credentials in a Hashgraph-based distributed ledger. Providers and facilities can obtain information that is pre-verified, securely stored, and readily available, creating an ongoing, self-auditing verification of provider work history and clinical reputation.
ReadyDoc will act fluidly between health systems and facilities across the U.S., allowing organizations to instantly verify work history and clinical reputations. In the event of an emergency like the Houston hurricane, facilities will be able staff up by vetting the credentials of qualified providers instantly. ReadyDoc eliminates redundancy and the need for third party verification organizations, letting medical professionals get to work sooner.
Babyscripts is a virtual care platform for prenatal care powered by mobile apps that drive better patient decision making, IOT devices for remote monitoring, and a host of population health tools to give providers access to patient data in real time.
Founders’ story
It seems unlikely that two childless bachelors, with no healthcare experience, would start a pregnancy company, but Juan Pablo Segura and Anish Sebastian founded Babyscripts, now the most impactful digital health tool in the obstetrical market. In 2014, with a passion to improve the current healthcare system due to family health struggles, business savvy, and the tenacity to succeed, these two former Deloitte consultants found themselves in front of the Chair of Obstetrics at George Washington School of Medicine & Health Sciences, Dr. Nancy Gaba, which started the journey of Babyscripts.
Marketing/promotion strategy
Babyscripts sells to health systems, private practices, and payers to support women’s health initiatives in pregnancy care. Babyscripts is then delivered by a care provider to an expectant mother at the beginning of her pregnancy. It is deployed through risk-specific modules that are tied to the clinical/social risk of a patient at the point of care.
Market opportunity
Each year, 4 million babies are born in the United States. Babyscripts works with the providers of care for these pregnancies – health systems and private practices – to support better access to care and better quality of care. Currently, nearly half of the counties in the United States don’t have access to an OB-GYN, according to the American College of Nurse-Midwives. The American Congress of Obstetricians and Gynecologists estimated that in 2020, there will be between 6,000 and 8,000 fewer OB-GYNs in the country than needed. Babyscripts is the only clinically validated tool that allows doctors to automate aspects of care, enabling there to be greater efficiency in the workflow, enabling doctors to touch more patients in a meaningful way.
Who are your competitors?
Our competition can be categorized in a few areas:
There are Consumer Maternity Apps in the market (ex. What to Expect, BabyCenter, The Bump)
Payer focused apps and programs for maternity (Wildflower Health, Ovia Pregnancy)
Non-Obstetric based clinical apps (ex. Wellpass, Vivify Health, Conversa Health)
How your company differentiates itself from the competition and what differentiates Babyscripts?
Babyscripts is the only platform that connects the clinical provider and patients together using technology, while at the same time lowering the cost of care. By including the provider and all of their guidance, specific information and advice into the equation, it ensures that a patient is getting information that aligns with her provider’s care plan, while keeping engagement high. Additionally, Babyscripts is the only clinical tool that is singularly focused on solving obstetrical problems.
Dthera digitized reminiscence therapy to enable people with dementia to see and hear their family and friends share familiar stories with them. Our first product, ReminX, is an artificial intelligence-powered consumer health product designed to improve the quality of life in individuals suffering from neurodegenerative diseases, such as dementia and Alzheimer’s disease, as well as seniors experiencing social isolation.
Founder’s story
Edward Cox, CEO, and David Keene, CTO, both had an upbringing similar to millions of families around the world – they grew up with a grandparent in the home. The special relationships with their grandparents included time hearing stories from the Greatest Generation – from growing up in humble beginnings to traveling across continents for war, peace, work, love and family. At the time, they didn’t realize they were engaging in reminiscence therapy, but did realize the impact social isolation can have on the elderly, especially those suffering from dementia or Alzheimer’s disease. With ReminX, their goal is to improve the quality-of-life for millions of elderly suffering from dementia by digitizing and proactively advocating reminiscence therapy and making it available to all.
Marketing/promotion strategy
Researchers concluded that ReminX holds great promise for bringing reminiscence therapy to people suffering from dementia. Dthera is exploring additional collaborations with non-profit organizations, medical centers and elder care facilities. ReminX is available for purchase by families, caregivers and administrators at senior assistant living centers through direct response marketing. Complete this form to find out where to purchase ReminiX.
Market opportunity
Our target market is the 46.8 million people worldwide living with dementia from Alzheimer’s, as well as from other neurodegenerative conditions. In the US alone, the Alzheimer Association estimated 5.7 million Americans have the disease and the cost to care for Alzheimer’s and other dementias will reach more than $277 billion in 2018. Dthera is focused on creating and delivering digital therapeutics that bring medically- validated treatments, such as reminiscence therapy, to patients suffering from dementia and severe forms of social isolation, to ease symptoms and create a better quality-of-life for them and their caregivers.
Who are your competitors?
In the digital therapeutics space, we are one of the only companies developing products for the elder care market, including dementia patients, but also people suffering from extreme social isolation.
As far as products to reach this group of the elderly, other tablets, social media or photo sharing sites could seem to be competitors with ReminX, but these products are not actually suited to this patient market. Apps and most tablets are too complicated for patients suffering from dementia to use, and none of these vehicles have active involvement of family members in the story-creation process designed into them. ReminX proprietary software includes an AI-interface app that engages family members to upload content and then optimizes it, and proprietary facial recognition software in the tablet provides feedback on what’s most effective.
Dthera designed ReminX with the elderly, their caregivers and families in mind. It automatically creates elegant documentary-like videos and plays stories on demand. There is no interface to learn, simply picking up the tablet starts stories and setting it down stops them.
With a mission to improve the lives of people living with diabetes and chronic conditions worldwide, Fit4D delivers scalable and effective programs through an optimized mix of technology human-based interactions.
Founder’s story:
At just 36 years old, David Weingard was diagnosed with Type 1 diabetes. With no family history of diabetes, he was confused and overwhelmed about the diagnosis. He had two sessions with his doctor on how to use insulin and that was it. Having received limited support and education on his diagnosis, Weingard was left to manage his diabetes on his own and needed help.
He then found Cecilia, a certified diabetes educator (CDE), who compassionately gave him the correct steps to follow to help him become productive again, personally and professionally. Cecilia sparked an idea for Weingard – to scale the personalized coaching he received, to millions of people living with diabetes, but using a technology platform. With the daily vigilance and management of his diabetes, he left his corporate job and founded Fit4D.
Market opportunity
Fit4D has established business partnerships with clients that include major health plans and providers such as Humana, HealthFirst and several Blue Cross Blue Shield plans, along with major pharmaceutical and medical device companies. The company delivers scalable and cost-effective diabetes management programs through an optimized mix of human-based touch points and technology to deliver measurable outcomes in an affordable manner.
Fit4D is driving improvements in diabetes outcomes across the socio-economic spectrum, achieving a relatively high enrollment rate, lowering blood sugar levels, and delivering significant cost-savings and ROI for clients.
Results include:
20 percent increase in adherence leads to three times increase in ROI for pharma/device companies.
One- to two-point reduction in HbA1c levels demonstrates improved health outcomes for enrolled patients.
28 percent enrollment rate saves $380 per patient for payers and providers.
More than 95 percent patient engagement rate
Who are your competitors?
Fit4D is unique in that we scale and deliver personalized one-on-one support through the optimization of human touch and technology. There are other companies in the market that are combining patient healthcare services with a heavy focus on technology, such as Livongo and Omada; however, they don’t offer a personalized patient approach to diabetes. Fit4D emphasis on combining human touch with a dedicated CDE throughout the length of the program, allowing the patient to build a strong fruitful coaching relationship. As a result, our service is highly valued for the likes of payers, providers, pharma and medical device companies.